---
input_text: 'Dravet syndrome: Treatment options and management of prolonged seizures.
  Over time, with careful delineation of Dravet syndrome, we have gained experience
  in treatments most likely to lead to improvement in seizures, as well as those that
  should be avoided. Sodium valproate, clobazam, stiripentol, and topiramate are all
  medications that may lead to benefit, as well as the ketogenic diet. Bromides may
  be utilized in resistant cases. However, equally important are outlining prompt
  rescue treatment for prolonged seizures and avoidance of precipitants. Newer agents
  including cannabidiol and fenfluramine have been demonstrated to be of benefit in
  clinical trials. We propose an algorithm for management, but appreciate that the
  positioning of newer agents is yet to be established.'
raw_completion_output: |-
  primary_disease: Dravet syndrome
  medical_actions: Treatment options;Management of prolonged seizures;Utilization of sodium valproate;Utilization of clobazam;Utilization of stiripentol;Utilization of topiramate;Following the ketogenic diet;Utilization of bromides;Rescue treatment for prolonged seizures;Avoidance of precipitants;Clinical trials for cannabidiol;Clinical trials for fenfluramine;Propose an algorithm for management
  symptoms: Seizures;Prolonged seizures
  chemicals: Sodium valproate;Clobazam;Stiripentol;Topiramate;Bromides;Cannabidiol;Fenfluramine
  action_annotation_relationships: Treatment options TREATS Seizures IN Dravet syndrome;Management of prolonged seizures TREATS Prolonged seizures IN Dravet syndrome;Utilization of sodium valproate TREATS Seizures IN Dravet syndrome;Utilization of clobazam TREATS Seizures IN Dravet syndrome;Utilization of stiripentol TREATS Seizures IN Dravet syndrome;Utilization of topiramate TREATS Seizures IN Dravet syndrome;Following the ketogenic diet TREATS Seizures IN Dravet syndrome;Utilization of bromides TREATS Seizures IN Dravet syndrome;Rescue treatment for prolonged seizures TREATS Prolonged seizures IN Dravet syndrome;Avoidance of precipitants PREVENTS Seizures IN Dravet syndrome;Clinical trials for cannabidiol (with cannabidiol) TREATS Seizures IN Dravet syndrome;Clinical trials for fenfluramine (with fenfluramine) TREATS Seizures IN Dravet syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Clinical trials for fenfluramine (with fenfluramine) TREATS Seizures IN Dravet syndrome

  ===

extracted_object:
  primary_disease: MONDO:0100135
  medical_actions:
    - Treatment options
    - Management of prolonged seizures
    - Utilization of sodium valproate
    - Utilization of clobazam
    - Utilization of stiripentol
    - Utilization of topiramate
    - Following the ketogenic diet
    - Utilization of bromides
    - Rescue treatment for prolonged seizures
    - Avoidance of precipitants
    - Clinical trials for cannabidiol
    - Clinical trials for fenfluramine
    - Propose an algorithm for management
  symptoms:
    - HP:0001250
    - HP:0002133
  chemicals:
    - CHEBI:9925
    - CHEBI:31413
    - CHEBI:228488
    - CHEBI:63631
    - CHEBI:15858
    - CHEBI:69478
    - CHEBI:5000
  action_annotation_relationships:
    - subject: Treatment options
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
    - subject: Management of prolonged seizures
      predicate: TREATS
      object: HP:0002133
      qualifier: MONDO:0100135
    - subject: Utilization of sodium valproate
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:9925
    - subject: Utilization of clobazam
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:31413
    - subject: Utilization of stiripentol
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:228488
    - subject: Utilization of topiramate
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:63631
    - subject: Following the ketogenic diet
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: ketogenic diet
    - subject: Utilization of bromides
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:15858
    - subject: Rescue treatment for prolonged seizures
      predicate: TREATS
      object: HP:0002133
      qualifier: MONDO:0100135
    - subject: Avoidance of precipitants
      predicate: PREVENTS
      object: HP:0001250
      qualifier: MONDO:0100135
    - subject: Clinical trials
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_qualifier: with cannabidiol
      subject_extension: CHEBI:69478
    - subject: Clinical trials
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_qualifier: with fenfluramine
      subject_extension: CHEBI:5000
named_entities:
  - id: MONDO:0100135
    label: Dravet syndrome
  - id: MAXO:0001187
    label: hysteroscopy
  - id: CHEBI:44915
    label: propofol
  - id: CHEBI:119915
    label: fentanyl
  - id: CHEBI:9130
    label: sevoflurane
  - id: HP:0001250
    label: seizures
  - id: CHEBI:6443
    label: Mirena
  - id: MONDO:0002602
    label: Central nervous system diseases
  - id: HP:0002011
    label: central nervous system diseases
  - id: MONDO:0005027
    label: Epilepsy
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0000988
    label: Rash
  - id: CHEBI:228488
    label: Stiripentol
  - id: CHEBI:60654
    label: Valproate
  - id: CHEBI:69478
    label: Cannabidiol
  - id: CHEBI:80634
    label: 2-propyl-4-pentenoic acid (4-ene-VPA)
  - id: HP:0002373
    label: Febrile seizures
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:31413
    label: clobazam (CLB)
  - id: HP:0010819
    label: drop seizures
  - id: HP:0002329
    label: somnolence
  - id: HP:0004396
    label: decreased appetite
  - id: CHEBI:9925
    label: sodium valproate
  - id: MONDO:0016532
    label: Lennox-Gastaut syndrome
  - id: HP:0000729
    label: Autistic behaviors
  - id: HP:0033258
    label: Sudden unexpected death in epilepsy
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0002125
    label: Status epilepticus
  - id: HP:0032656
    label: Febrile status epilepticus
  - id: MAXO:0001017
    label: vaccination
  - id: HP:0002069
    label: Generalized tonic-clonic seizure
  - id: CHEBI:3359
    label: CBDA
  - id: CHEBI:167557
    label: CBCA
  - id: CHEBI:66964
    label: Delta9-tetrahydrocannabinol (THC)
  - id: CHEBI:39867
    label: Valproic acid
  - id: CHEBI:5000
    label: Fenfluramine
  - id: HP:0033349
    label: recurrent seizures
  - id: MAXO:0000058
    label: Drug treatment
  - id: HP:0020219
    label: motor seizures
  - id: CHEBI:76720
    label: Antisense oligonucleotides
  - id: MAXO:0001593
    label: ASO therapy
  - id: HP:0012378
    label: Fatigue
  - id: HP:0001945
    label: Pyrexia
  - id: HP:0001654
    label: valvular heart disease
  - id: HP:0002092
    label: pulmonary arterial hypertension
  - id: HP:0002133
    label: Status epilepticus
  - id: CHEBI:17115
    label: vaccine(s)
  - id: MONDO:0100062
    label: Developmental and/or epileptic encephalopathies (DEE)
  - id: HP:0001260
    label: dysarthria
  - id: HP:0001254
    label: lethargy
  - id: HP:0002315
    label: headache
  - id: CHEBI:233158
    label: soticlestat
  - id: CHEBI:34310
    label: 24S-hydroxycholesterol (24HC)
  - id: CHEBI:9586
    label: Tiagabine
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0000708
    label: behavioral problems
  - id: CHEBI:16113
    label: Cholesterol
  - id: MAXO:0001394
    label: Oral administration
  - id: CHEBI:173124
    label: 2-linoleoyl glycerol (2-LG)
  - id: CHEBI:52392
    label: 2-AG
  - id: CHEBI:2700
    label: anandamide
  - id: CHEBI:52640
    label: N-acylethanolamines
  - id: CHEBI:35623
    label: Anticonvulsants
  - id: MAXO:0000942
    label: Vagus nerve stimulation (VNS)
  - id: HP:0002360
    label: Sleep disturbance
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:42638
    label: fenfluramine (FFA)
  - id: HP:0032794
    label: Myoclonic seizures
  - id: CHEBI:190616
    label: N-desmethylclobazam
  - id: MONDO:0013801
    label: SCN8A encephalopathy
  - id: HP:0001263
    label: Developmental delay
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:35493
    label: antipyretics
  - id: MAXO:0000932
    label: Electroencephalography (EEG)
  - id: HP:0002353
    label: EEG abnormalities
  - id: CHEBI:73601
    label: <Ketogenic diet (KD)>
  - id: CHEBI:49575
    label: diazepam
  - id: CHEBI:6931
    label: midazolam
  - id: CHEBI:3756
    label: clonazepam
  - id: CHEBI:22720
    label: Benzodiazepines
  - id: MONDO:0010083
    label: Succinic semialdehyde dehydrogenase deficiency
  - id: HP:0000739
    label: Anxiety
  - id: CHEBI:10127
    label: Zonisamide
  - id: CHEBI:87016
    label: Eslicarbazepine acetate
  - id: CHEBI:135939
    label: Lacosamide
  - id: MONDO:0700092
    label: Neurodevelopmental disorders (NDDs)
  - id: CHEBI:63631
    label: Topiramate
  - id: CHEBI:15858
    label: Bromides
